In the news: Outbound investment picks up in the US and GSK executives likely to be charged

Outbound investment into the US reached record levels, boosted in part by the closing of Shuanghui's acquisition of Smithfield. GSK's executives under investigation are likely to be charged but the company may avoid penalties

3 minute readNovember 07, 2013 at 07:45 AM

clpstaff

& clp articles

China FDI reaches new heights in the US

Rhodium Group released their Chinese FDI in the United States: Q3 2013 Update last week. Shuanghui International's $7.1 billion acquisition of Smithfield marked the largest Chinese acquisition in the US to date.

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)